...
机译:AIDI注射加上铂族化疗,用于阶段IIIB / IV非小细胞肺癌:PRISMA指南后42个RCT的META分析
Macau Univ Sci &
Technol State Key Lab Qual Res Chinese Med Macau Peoples R China;
Nanjing Univ Chinese Med Sch Med &
Life Sci Nanjing Jiangsu Peoples R China;
Macau Univ Sci &
Technol State Key Lab Qual Res Chinese Med Macau Peoples R China;
Macau Univ Sci &
Technol Fac Chinese Med Macau Peoples R China;
Macau Univ Sci &
Technol State Key Lab Qual Res Chinese Med Macau Peoples R China;
Macau Univ Sci &
Technol Fac Chinese Med Macau Peoples R China;
Aidi injection; NSCLC; Stage IIIB/IV; Chemotherapy; Efficacy; Safety; Toxicity; Systematic review; Meta-analysis; Trial Sequential Analysis;
机译:AIDI注射加上铂族化疗,用于阶段IIIB / IV非小细胞肺癌:PRISMA指南后42个RCT的META分析
机译:复方禁毒注射加上铂类化学疗法IIIB / IV非小细胞肺癌:普遍指南后随机临床试验的荟萃分析的方案
机译:复方甘珍注射联合铂类化疗,用于III阶段/ IV非小细胞肺癌:普遍指南后37个RCT的META分析
机译:细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
机译:晚期(IIIB和IV)非小细胞肺癌患者症状管理的评估
机译:复方苦参注射液联合铂类化学疗法治疗III / IV期非小细胞肺癌:根据PRISMA指南对37个RCT进行荟萃分析
机译:复合武仁注射加上铂类化疗阶段IIIB / IV非小细胞肺癌